Found 10 hits for monomerid = 204102 Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM204102
(US9539260, H3 | US9539260, H4 | US9763952, Example...)Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3COCCO3)cc12 |r,w:25.28| Show InChI InChI=1S/C24H29N3O7S/c1-16-11-17(13-25-23(16)35(2,29)30)27-7-8-32-21-4-3-18(12-20(21)27)34-19-5-6-26(14-19)24(28)22-15-31-9-10-33-22/h3-4,11-13,19,22H,5-10,14-15H2,1-2H3/t19-,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 559 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM204102
(US9539260, H3 | US9539260, H4 | US9763952, Example...)Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3COCCO3)cc12 |r,w:25.28| Show InChI InChI=1S/C24H29N3O7S/c1-16-11-17(13-25-23(16)35(2,29)30)27-7-8-32-21-4-3-18(12-20(21)27)34-19-5-6-26(14-19)24(28)22-15-31-9-10-33-22/h3-4,11-13,19,22H,5-10,14-15H2,1-2H3/t19-,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM204102
(US9539260, H3 | US9539260, H4 | US9763952, Example...)Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3COCCO3)cc12 |r,w:25.28| Show InChI InChI=1S/C24H29N3O7S/c1-16-11-17(13-25-23(16)35(2,29)30)27-7-8-32-21-4-3-18(12-20(21)27)34-19-5-6-26(14-19)24(28)22-15-31-9-10-33-22/h3-4,11-13,19,22H,5-10,14-15H2,1-2H3/t19-,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 848 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM204102
(US9539260, H3 | US9539260, H4 | US9763952, Example...)Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3COCCO3)cc12 |r,w:25.28| Show InChI InChI=1S/C24H29N3O7S/c1-16-11-17(13-25-23(16)35(2,29)30)27-7-8-32-21-4-3-18(12-20(21)27)34-19-5-6-26(14-19)24(28)22-15-31-9-10-33-22/h3-4,11-13,19,22H,5-10,14-15H2,1-2H3/t19-,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | 25 |
NOVARTIS AG
US Patent
| Assay Description Determination of Enzymatic PI3K Alpha and PI3K Delta Isoform Inhibition1.1 Test of Lipid Kinase ActivityThe efficacy of the compounds of examples 1-1... |
US Patent US9539260 (2017)
BindingDB Entry DOI: 10.7270/Q2W37TH1 |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM204102
(US9539260, H3 | US9539260, H4 | US9763952, Example...)Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3COCCO3)cc12 |r,w:25.28| Show InChI InChI=1S/C24H29N3O7S/c1-16-11-17(13-25-23(16)35(2,29)30)27-7-8-32-21-4-3-18(12-20(21)27)34-19-5-6-26(14-19)24(28)22-15-31-9-10-33-22/h3-4,11-13,19,22H,5-10,14-15H2,1-2H3/t19-,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 11 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM204102
(US9539260, H3 | US9539260, H4 | US9763952, Example...)Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3COCCO3)cc12 |r,w:25.28| Show InChI InChI=1S/C24H29N3O7S/c1-16-11-17(13-25-23(16)35(2,29)30)27-7-8-32-21-4-3-18(12-20(21)27)34-19-5-6-26(14-19)24(28)22-15-31-9-10-33-22/h3-4,11-13,19,22H,5-10,14-15H2,1-2H3/t19-,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | <3 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM204102
(US9539260, H3 | US9539260, H4 | US9763952, Example...)Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3COCCO3)cc12 |r,w:25.28| Show InChI InChI=1S/C24H29N3O7S/c1-16-11-17(13-25-23(16)35(2,29)30)27-7-8-32-21-4-3-18(12-20(21)27)34-19-5-6-26(14-19)24(28)22-15-31-9-10-33-22/h3-4,11-13,19,22H,5-10,14-15H2,1-2H3/t19-,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 559 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| Assay Description The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and p... |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
(Homo sapiens (Human)) | BDBM204102
(US9539260, H3 | US9539260, H4 | US9763952, Example...)Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3COCCO3)cc12 |r,w:25.28| Show InChI InChI=1S/C24H29N3O7S/c1-16-11-17(13-25-23(16)35(2,29)30)27-7-8-32-21-4-3-18(12-20(21)27)34-19-5-6-26(14-19)24(28)22-15-31-9-10-33-22/h3-4,11-13,19,22H,5-10,14-15H2,1-2H3/t19-,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt UniProtKB/TrEMBL
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 8 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM204102
(US9539260, H3 | US9539260, H4 | US9763952, Example...)Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3COCCO3)cc12 |r,w:25.28| Show InChI InChI=1S/C24H29N3O7S/c1-16-11-17(13-25-23(16)35(2,29)30)27-7-8-32-21-4-3-18(12-20(21)27)34-19-5-6-26(14-19)24(28)22-15-31-9-10-33-22/h3-4,11-13,19,22H,5-10,14-15H2,1-2H3/t19-,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 848 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| Assay Description The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and p... |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
(Homo sapiens (Human)) | BDBM204102
(US9539260, H3 | US9539260, H4 | US9763952, Example...)Show SMILES Cc1cc(cnc1S(C)(=O)=O)N1CCOc2ccc(O[C@H]3CCN(C3)C(=O)C3COCCO3)cc12 |r,w:25.28| Show InChI InChI=1S/C24H29N3O7S/c1-16-11-17(13-25-23(16)35(2,29)30)27-7-8-32-21-4-3-18(12-20(21)27)34-19-5-6-26(14-19)24(28)22-15-31-9-10-33-22/h3-4,11-13,19,22H,5-10,14-15H2,1-2H3/t19-,22?/m0/s1 | PDB MMDB
NCI pathway Reactome pathway KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar AffyNet
| PC cid PC sid UniChem
| US Patent
| n/a | n/a | 801 | n/a | n/a | n/a | n/a | n/a | n/a |
NOVARTIS AG
US Patent
| Assay Description The kinase reaction is performed in a final volume of 50 μl per well of a half area COSTAR, 96 well plate. The final concentrations of ATP and p... |
US Patent US9763952 (2017)
BindingDB Entry DOI: 10.7270/Q2V40X9Z |
More data for this Ligand-Target Pair | |